T
5G3
vs
F
FTSE Straits Times Singapore
Over the past 12 months, 5G3 has outperformed FTSE Straits Times Singapore, delivering a return of +2% compared to the FTSE Straits Times Singapore's 0% growth.
Stocks Performance
5G3 vs FTSE Straits Times Singapore
Performance Gap
5G3 vs FTSE Straits Times Singapore
Performance By Year
5G3 vs FTSE Straits Times Singapore
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Talkmed Group Ltd
Glance View
TalkMed Group Ltd. is an investment holding company, which engages in the provision of medical oncology, stem cell transplants, and palliative care services. The firm is a provider of medical oncology and palliative care health care services in Singapore. The firm operates through two segments: Oncology services, and Cellular and gene therapy related products and services. The Oncology services provide specialist doctors and clinical staff to Parkway Cancer Centre (PCC), a division of Parkway Hospitals Singapore Pte. Ltd. for the provision of specialist medical oncology services (consultancy services). The company also provides consultancy services to Thu Cuc International General Hospital (TCH), to enable TCH to operate a medical center for the provision of oncology services in Hanoi, Vietnam. The company also provides consultancy services to the patients in Beijing and Chongqing. Cellular and gene therapy-related products and services include the provision of goods and services related to cellular and gene therapy through its subsidiary, CellVec Pte. Ltd. (CellVec).
